Key stats
About Invesco S&P SmallCap Health Care ETF
Home page
Inception date
Apr 7, 2010
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
PSCH targets US small-cap companies in the health care space. The fund pulls from the S&P SmallCap 600, a market-cap-weighted index that consists of US small-cap companies screened for size, liquidity, and financial viability. It specifically holds companies engaged in providing health care products, facilities and services, biotechnology, pharmaceuticals, as well as medical technology and supplies. Selected securities are weighted by market cap and are constrained at each quarterly rebalance, such that individual securities will not exceed 22.5% weight and the aggregate weight of securities with over 4.5% allocation is capped at 45% weight of the portfolio. For more speculative investors, PSCH is potentially a great alternative play on the sector.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks100.01%
Health Technology76.06%
Health Services13.10%
Finance4.21%
Technology Services3.28%
Commercial Services2.13%
Process Industries1.22%
Bonds, Cash & Other−0.01%
Cash−0.01%
Stock breakdown by region
North America96.49%
Europe3.51%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
PSCH invests in stocks. The fund's major sectors are Health Technology, with 76.07% stocks, and Health Services, with 13.10% of the basket. The assets are mostly located in the North America region.
PSCH top holdings are Corcept Therapeutics Incorporated. and Glaukos Corp, occupying 5.02% and 4.11% of the portfolio correspondingly.
PSCH last dividends amounted to 0.00 USD. The quarter before, the issuer paid 0.01 USD in dividends, which shows a 613.07% decrease.
PSCH assets under management is 134.53 M USD. It's fallen 5.67% over the last month.
PSCH fund flows account for −48.65 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, PSCH pays dividends to its holders with the dividend yield of 0.09%. The last dividend (Jun 27, 2025) amounted to 0.00 USD. The dividends are paid quarterly.
PSCH shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Apr 7, 2010, and its management style is Passive.
PSCH expense ratio is 0.29% meaning you'd have to pay 0.29% of your investment to help manage the fund.
PSCH follows the S&P SmallCap 600 Capped Health Care Index - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
PSCH invests in stocks.
PSCH price has fallen by −2.00% over the last month, and its yearly performance shows a −15.95% decrease. See more dynamics on PSCH price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.94% over the last month, showed a 0.62% increase in three-month performance and has decreased by −14.44% in a year.
NAV returns, another gauge of an ETF dynamics, have fallen by −0.94% over the last month, showed a 0.62% increase in three-month performance and has decreased by −14.44% in a year.
PSCH trades at a premium (0.03%) meaning the ETF is trading at a higher price than the calculated NAV.